RecruitingNCT06883201
Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer
Sponsor
Regina Elena Cancer Institute
Enrollment
78 participants
Start Date
Jan 31, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Evaluation of the percentage of transfusions in patients with breast cancer undergoing surgery after preventive treatment with haematinics.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria5
- age \> 18 years;
- patients diagnosed with histologically confirmed breast cancer and whether or not they have undergone neoadjuvant chemotherapy;
- patients who are candidates for destructive and reconstructive breast surgery or not;
- Hb values less than or equal to 11 g/dL and/or transferrin saturation less than or equal to 20%;
- written informed consent.
Exclusion Criteria3
- patients with known allergies to ferric carboxymaltose or its excipients;
- ferritin values greater than 500 ng/ml;
- patients unable to sign consent and comply with procedures.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06883201
Related Trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT053096553 locations
Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia
NCT0693085934 locations
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
NCT052915071 location